Skip to main content

7 Result(s)

within Chapter Remove this filter J. P. Droz Remove this filter Oncology Remove this filter

and

  1. No Access

    Chapter

    Cancer de la vessie/uretère

    Les tumeurs urothéliales sont des tumeurs fréquentes qui se développent aux dépens de l’arbre urinaire. Elles siègent le plus souvent dans la vessie mais elles peuvent aussi avoir comme origine le haut apparei...

    H. Boyle, A. Fléchon, J.-P. Droz in Thérapeutique du cancer (2011)

  2. No Access

    Chapter

    Traitement des formes de mauvais pronostic

    A. Fléchon, J.-P. Droz in Cancer du testicule (2006)

  3. No Access

    Chapter

    Testicular tumors

    Tumors of the testicles, although relatively infrequent (less than 1% of cancers in males), are still used as a model for study in oncology, principally as a result of their curability by chemotherapy.

    E.-Ch. Antoine, J.-P. Droz, D. Buthiau in CT and MRI in Oncology (1998)

  4. No Access

    Chapter and Conference Paper

    No advantage for the use of an early high-dose chemotherapy with autologous bone marrow transplantation in first-line treatment of poor risk non-seminomatous germ cell tumors

    The results of the treatment of non-seminomatous germ cell tumors (NSGCT) have been dramatically improved by Cisplatin-based chemotherapy regimens and selective indication of surgery. Approximately 80 % of all...

    H. Curé, J. P. Droz, J. L. Pico, P. Biron, P. Kerbrat… in Cancer Treatment An Update (1994)

  5. No Access

    Chapter and Conference Paper

    High-dose chemotherapy with hematologic rescue for high-risk non-seminomatous germ cell tumors

    Despite progress in the treatment of disseminated non-seminomatous germ cell tumors (NSGCT), 20–30%of patients do not achieve CR or relapse [1]. We evaluated high-dose chemotherapy (HDC) followed by autologous...

    J. L. Pico, J. P. Droz, E. Zambon… in Proceedings of the 3rd International Congr… (1991)

  6. No Access

    Chapter

    First Results of a Randomized Trial on Immunotherapy of Head and Neck Tumors

    Trials of active nonspecific immunotherapy as adjuvant therapy for tumors have increased dramatically in number since the results that have been published on acute leukemia [6] and melanoma [3, 5, 7–9]. In spi...

    J. L. Amiel, H. Sancho-Garnier… in Adjuvant Therapies and Markers of Post-Sur… (1979)

  7. No Access

    Chapter

    Effects of Treatment of Malignant Lymphomas on the Granulocytic Progenitor Cells (CFUc)

    Study of the after-effects of therapy on the healthy organs is one of the main preoccupations of oncology. Although progress in therapeutics has clearly improved the prognosis for malignant lymphomas, the afte...

    C. Parmentier, D. Maraninchi, N. Morardet, J. P. Droz… in Lymphoid Neoplasias II (1978)